AML Treatment By the AXL Inhibitor Bemcentinib in Combination with Cytarabine Shows Clinical Efficacy Related to TNFα and Cytotoxic Immune Cells: A Single-Cell Translational Study from the BGBC003 TrialNiklas Beumer,Jonas S. Waizenegger,Michael Heuser,Jörg Chromik,Grerk Sutamtewagul,Silke Kapp-Schwoerer,Monica Crugnola,Nicola Di Renzo,Roberto M. Lemoli,Daniele G. Mattei,Walter Fiedler, Yesid Alvarado-Valero, David Micklem,Linn H. Nilsson,Noelly Madeleine, Nigel McCracken, Cristina Oliva,Claudia Gorcea-Carson,Lisa-Marie Rieckmann,Jenny KrauseBlood（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
